Reliq Health Technologies Inc.
RQHTF
$0.0001
-$0.0099-99.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 76.51% | 78.67% | 108.44% | 448.59% | 469.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.51% | 78.67% | 108.44% | 448.59% | 469.00% |
| Cost of Revenue | 63.99% | 159.75% | 178.91% | 2,753.60% | 249.27% |
| Gross Profit | 83.23% | 50.19% | 81.12% | 149.81% | 759.55% |
| SG&A Expenses | 37.59% | -55.95% | -61.81% | -25.46% | -50.70% |
| Depreciation & Amortization | -0.47% | 2.35% | -0.47% | -66.75% | 251.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.48% | -8.17% | -30.61% | 35.00% | 3.61% |
| Operating Income | 176.65% | 101.59% | 83.42% | 43.30% | 72.37% |
| Income Before Tax | 184.40% | 96.93% | 97.19% | 57.26% | 71.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 184.40% | 96.93% | 97.19% | 57.26% | 71.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 184.40% | 96.93% | 97.19% | 57.26% | 71.02% |
| EBIT | 176.65% | 101.59% | 83.42% | 43.30% | 72.37% |
| EBITDA | 183.18% | 101.61% | 83.95% | 42.61% | 73.17% |
| EPS Basic | 188.24% | 96.81% | 97.35% | 55.88% | 74.81% |
| Normalized Basic EPS | 185.71% | 96.55% | 97.46% | 56.25% | 75.29% |
| EPS Diluted | 188.24% | 96.81% | 97.35% | 55.88% | 74.81% |
| Normalized Diluted EPS | 185.71% | 96.55% | 97.46% | 56.25% | 75.29% |
| Average Basic Shares Outstanding | -1.90% | 7.11% | 7.20% | -1.77% | 14.05% |
| Average Diluted Shares Outstanding | -1.90% | 7.11% | 7.20% | -1.77% | 14.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
